MedPath

Clinical study on Melasma.

Phase 2
Conditions
Health Condition 1: L811- Chloasma
Registration Number
CTRI/2024/04/066027
Lead Sponsor
ATIONAL RESEARCH INSTITUTE OF UNANI MEDICINE FOR SKIN DISORDERS
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Participants of any gender in the age group of 18-60 years.

Participants having bilateral symmetrical or asymmetrical brown macules on face (nose, forehead, upper lip and cheeks & chin ).

Participants who are willing to participate and comply with the protocol and to sign IEC approved ICF.

Exclusion Criteria

The following participants will be excluded from the study:

Participants aged less than 18 and more than 60 years.

Pregnant and lactating women.

Known cases of significant Pulmonary/Cardiovascular/Hepato-renal Dysfunction, Malignancy, Endocrine disorders, HIV infection, AIDS, etc.

Known allergy, sensitivity or intolerance to the study drug or any of its ingredients

Participants with active alcohol intake and/or drug abuse

Those unwillingly to come for regular follow-up for the entire duration of the study and any patient considered not eligible in the investigator’s discretion.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath